Detalles de la búsqueda
1.
Quality of life and outcome of patients with metastatic pancreatic cancer receiving first-line chemotherapy with nab-paclitaxel and gemcitabine: Real-life results from the prospective QOLIXANE trial of the Platform for Outcome, Quality of Life and Translational Research on Pancreatic Cancer registry.
Int J Cancer
; 148(6): 1478-1488, 2021 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33038277
2.
Adding cetuximab to paclitaxel and carboplatin for first-line treatment of carcinoma of unknown primary (CUP): results of the Phase 2 AIO trial PACET-CUP.
Br J Cancer
; 124(4): 721-727, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33235314
3.
Ipilimumab or FOLFOX with Nivolumab and Trastuzumab in previously untreated HER2-positive locally advanced or metastatic EsophagoGastric Adenocarcinoma - the randomized phase 2 INTEGA trial (AIO STO 0217).
BMC Cancer
; 20(1): 503, 2020 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32487035
4.
Ramucirumab, Avelumab, and Paclitaxel as Second-Line Treatment in Esophagogastric Adenocarcinoma: The Phase 2 RAP (AIO-STO-0218) Nonrandomized Controlled Trial.
JAMA Netw Open
; 7(1): e2352830, 2024 Jan 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38261316
5.
Nanoliposomal irinotecan and fluorouracil plus leucovorin versus fluorouracil plus leucovorin in patients with cholangiocarcinoma and gallbladder carcinoma previously treated with gemcitabine-based therapies (AIO NALIRICC): a multicentre, open-label, randomised, phase 2 trial.
Lancet Gastroenterol Hepatol
; 2024 Jun 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38870977
6.
Perioperative Atezolizumab Plus Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel for Resectable Esophagogastric Cancer: Interim Results From the Randomized, Multicenter, Phase II/III DANTE/IKF-s633 Trial.
J Clin Oncol
; 42(4): 410-420, 2024 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37963317
7.
Capecitabine and bevacizumab for non-resectable metastatic colorectal cancer patients: final results from phase II AIO KRK 0105 trial.
BMC Cancer
; 13: 454, 2013 Oct 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-24090011
8.
Anticoagulation Therapy in Cancer Patients with Thrombosis in the Outpatient Sector of Germany (The CERTIFICAT Initiative)-German Practice of Anticoagulation Therapy of Cancer Patients with Thrombosis.
Hamostaseologie
; 42(3): 166-173, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-34879420
9.
Prophylaxis of chemotherapy-induced neutropenia with lipegfilgrastim in patients with lung cancer: final results from the non-interventional study NADIR.
Curr Med Res Opin
; 38(12): 2191-2199, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36047998
10.
Panitumumab Plus Fluorouracil and Folinic Acid Versus Fluorouracil and Folinic Acid Alone as Maintenance Therapy in RAS Wild-Type Metastatic Colorectal Cancer: The Randomized PANAMA Trial (AIO KRK 0212).
J Clin Oncol
; 40(1): 72-82, 2022 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34533973
11.
FLOT Versus FLOT/Trastuzumab/Pertuzumab Perioperative Therapy of Human Epidermal Growth Factor Receptor 2-Positive Resectable Esophagogastric Adenocarcinoma: A Randomized Phase II Trial of the AIO EGA Study Group.
J Clin Oncol
; 40(32): 3750-3761, 2022 11 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35709415
12.
Efficacy of Ipilimumab vs FOLFOX in Combination With Nivolumab and Trastuzumab in Patients With Previously Untreated ERBB2-Positive Esophagogastric Adenocarcinoma: The AIO INTEGA Randomized Clinical Trial.
JAMA Oncol
; 8(8): 1150-1158, 2022 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35737383
13.
HER2 Expression, Test Deviations, and Their Impact on Survival in Metastatic Gastric Cancer: Results From the Prospective Multicenter VARIANZ Study.
J Clin Oncol
; 39(13): 1468-1478, 2021 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33764808
14.
Preoperative short-course radiotherapy versus combined radiochemotherapy in locally advanced rectal cancer: a multi-centre prospectively randomised study of the Berlin Cancer Society.
BMC Cancer
; 9: 50, 2009 Feb 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-19200365
15.
Phase II trial of capecitabine and oxaliplatin in patients with adeno- and undifferentiated carcinoma of unknown primary.
Onkologie
; 32(4): 162-6, 2009 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-19372710
16.
Oxaliplatin in combination with 5-fluorouracil/leucovorin or capecitabine in elderly patients with metastatic colorectal cancer.
Clin Colorectal Cancer
; 7(1): 60-4, 2008 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-18279579
17.
Misplacement of a Port Catheter: A Differentiated View.
Case Rep Radiol
; 2017: 1640431, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-29441212
18.
Docetaxel and continuous-infusion fluorouracil versus epirubicin, cisplatin, and fluorouracil for advanced gastric adenocarcinoma: a randomized phase II study.
J Clin Oncol
; 23(3): 494-501, 2005 Jan 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-15659494
19.
[Recent progress in the treatment of colorectal cancer]. / Jüngste Fortschritte in der Therapie des Kolonkarzinoms.
Med Klin (Munich)
; 101(2): 114-9, 2006 Feb 15.
Artículo
en Alemán
| MEDLINE | ID: mdl-16501908
20.
5-Fluorouracil, leucovorin, and oxaliplatin (mFOLFOX6) plus sunitinib or bevacizumab as first-line treatment for metastatic colorectal cancer: a randomized Phase IIb study.
Cancer Manag Res
; 7: 165-73, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26109878